Evogene LTD. (EVGN) SEC Filings — 2024
26 SEC filings for Evogene LTD. (EVGN) in 2024.
Filings
- Evogene Ltd. Schedules Special Shareholder Meeting for Feb 5, 2025 — 6-K · Dec 30, 2024
- Evogene Subsidiary Lavie Bio's Licensing Deal Terminated by Corteva — 6-K · Nov 27, 2024
- Evogene Ltd. Reports Q3 2024 Financial Results — 6-K · Nov 21, 2024
- Evogene LTD. SC 13G/A Filing — SC 13G/A · Oct 15, 2024
- Evogene Ltd. CTO Mark Kapel to Depart — 6-K · Sep 17, 2024
- Evogene Ltd. Files 6-K with Q2 Financials — 6-K · Sep 16, 2024
- Evogene Ltd. Raises Capital Through Share Offering — 6-K · Aug 23, 2024
- Evogene Ltd. Reports Q2 2024 Financial Results — 6-K · Aug 22, 2024
- Evogene Regains Nasdaq Minimum Bid Price Compliance — 6-K · Aug 12, 2024
- Evogene Ltd. Announces 1-for-10 Reverse Share Split — 6-K · Jul 23, 2024
- Evogene Subsidiary Casterra Secures $440K Order — 6-K · Jun 25, 2024
- Evogene Ltd. CPO Nir Arbel to Step Down — 6-K · Jun 20, 2024
- Evogene Shareholders Approve Proposals, Reject CEO Stock Options — 6-K · Jun 17, 2024
- Evogene Annual Meeting Adjourned Due to Lack of Quorum — 6-K · Jun 6, 2024
- Evogene Ltd. Files May 2024 6-K Report — 6-K · May 29, 2024
- Evogene Ltd. Reports Q1 2024 Financial Results — 6-K · May 23, 2024
- Evogene Ltd. Schedules 2024 Annual Shareholder Meeting — 6-K · Apr 30, 2024
- Evogene Launches Finally Foods for Plant-Based Protein — 6-K · Apr 2, 2024
- Evogene Ltd. Files 20-F Annual Report for Fiscal Year Ended December 31, 2023 — 20-F · Mar 28, 2024
- Evogene Ltd. Receives Nasdaq Letter — 6-K · Mar 20, 2024
- Evogene Ltd. Reports Q4 and FY 2023 Financial Results — 6-K · Mar 7, 2024
- Evogene Subsidiary Ag Plenus Appoints Dr. Dan Jacob Gelvan as CEO — 6-K · Feb 22, 2024
- Evogene Subsidiary Ag Plenus Partners with Bayer for Weed Control — 6-K · Feb 21, 2024
- Evogene LTD. SC 13G Filing — SC 13G · Feb 14, 2024
- Evogene's Biomica Completes Phase I Enrollment for Cancer Drug BMC128 — 6-K · Jan 17, 2024
- Evogene Files Investor Presentation, CEO Haviv to Present — 6-K · Jan 9, 2024